Table 2: Study patients characteristics.
|
|
All subjects (n = 10) |
All subjects Percentage |
Product Evaluation Subjects* (n= 4) |
Product Evaluation Percentage |
|
|
Gender |
Male |
7 |
70 |
3 |
75 |
|
|
Female |
3 |
30 |
1 |
25 |
|
Age (years) |
|
59.9 (mean) |
6.97 (SD) |
60 (mean) |
4.18 (SD) |
|
Ethnicity |
Caucasian |
8 |
80 |
3 |
75 |
|
|
Hispanic |
1 |
10 |
0 |
0 |
|
|
Asian |
1 |
10 |
1 |
25 |
|
Smoker |
Current or former |
3 |
30 |
1 |
25 |
|
Vitamin/ Mineral Use |
(yes) |
4 |
40 |
1 |
25 |
|
Cancer Location |
SCC Tonsil p16 positive |
6 |
60 |
3 |
75 |
|
|
Base of Tongue p16 positive |
3 |
30 |
1 |
25 |
|
|
Oral Tongue p16 positive |
1 |
10 |
0 |
0 |
Product Evaluation subjects are a subset of “all” subjects. Ten subjects completed the study (6 during treatment and 8 after treatment with four of these during and after treatment); 4 of these patients completed the product evaluation (one during and three after treatment).